The C5i Supply Chain Command Center combines connected intelligence to deliver these capabilities by integrating data, analytics, insights, and action into a unified mission-control platform designed for agility and coordinated execution.
Read here: https://t.co/xYr2iqtp1u
In his latest Forbes article, Ajith Sankaran, Executive Vice President at C5i, examines the “Hallucination Tax”—the ongoing cost enterprises pay when AI systems produce confident but false outputs.
Read here: https://t.co/xc2704kpKw
🚨FDA News🚨
The @US_FDA has accepted @ArcutisBio's supplemental New Drug Application (sNDA) for roflumilast (Zoryve) cream 0.3% in children aged 2-5 years with #psoriasis, potentially expanding the drug’s indication for this age range.
🔗View more here: https://t.co/rwB5rrXGZj
Are you ready for the transition to personalized therapy?
Experts discuss the cutting-edge science in prostate cancer management. See how new research is identifying specific signaling pathways that drive growth and resistance to traditional AR-targeted therapy.
Watch the full discussion ➡️ https://t.co/mWsWGCQRcU
#CME
Discover why CDMOs are vital in the rise of cell & gene therapies! Get your FREE eBook sponsored by Catalent: https://t.co/3zhD2E8WVJ #GeneTherapy#CDMO#CGT
Dr Chiranjiv Roy, Global Head – Data Sciences & Applied AI Practice at C5i, received the Visionary Data & AI Leader Award for his pioneering work in advancing applied and generative AI at enterprise scale at the BW Businessworld Chief Data & AI Officers Awards 2025.
🗣️ “The King is about to arrive!”- @White_Adam
🗣️ There’s seismic shifts in cricket and this guy has been at the centre of many of them.” - @copes9
Virat Kohli walks out for the final time in Australia wearing Indian colours 👑
#AUSvIND 🏏
Forrester’s Marketing Measurement and Optimization Services Landscape, Q3 2025, highlights how organizations are leveraging advanced marketing mix modeling.
We’re proud to be recognized in this report for our MMO offerings, which enables organizations to make informed investment.
After the news of me receiving the award recently, it is my pleasure to announce an award! 😊
Establishing an annual prize in 2023 in the honor of my parents, the Anita Gyawali-Ganesh Gyawali Health Research Award, to motivate young trainees in Nepal to pursue health research has been one of the biggest honors of my life.
This year, we are delighted to present the Anita Gyawali-Ganesh Gyawali Health Research award to Nitesh Kumar Karna , a 3rd-year medical student from BPKIHS, whose research has been accepted as an oral abstract at @myESMO Annual Meeting 2025 in Berlin.
The award was presented by my parents Anita Gyawali and Ganesh Gyawali on Sep 2, 2025 during a ceremony at Blood and Multispecialty Hospital, Kathmandu.
Congratulations to the recipient. We are delighted to do some part in encouraging good quality health research in Nepal.
https://t.co/3oxuvSZd0u
Agentic AI is here. But the real question isn’t what to automate, it’s which decisions to.
Smart leaders are rethinking service ops, blending AI with human judgment where it matters most.
Explore the framework that’s changing the game: https://t.co/TzerjON53Q
Energy start-ups are not yet embracing AI at the pace seen in other sectors
Only 2.3% of energy start-ups have an AI-related value proposition, lower than the 7% for life sciences & 4.3% for agriculture
Supportive policies are key to boosting innovation: https://t.co/Ga5qmKsDwo
#YouCanWithAI | #AI in life sciences is rapidly moving beyond traditional analytics. . In the near future, #intelligentagents could design lab experiments, monitor clinical trials in real time, or manage supply chain disruptions automatically without human oversight. Many leaders are ready for this shift, with high levels of comfort around AI making decisions in specific use cases.
Click here for more insights https://t.co/aiyWfKPP3r
#MakeTheDifference #lifesciences
#MEDIA: We're showcasing new findings from our global real-world data program of our treatment for symptomatic obstructive hypertrophic cardiomyopathy at #ESCCongress, including insights into diverse patient populations: https://t.co/H6FGZzxddJ
#MEDIA Announcing our first-of-its-kind RayzeBio site in Indianapolis, a cutting-edge U.S. manufacturing facility advancing our mission to deliver innovative medicines to patients.